Transgenic mice carrying a tetracycline-inducible, truncated transforming growth factor beta receptor (TβRII)

被引:14
|
作者
Frugier, T
Koishi, K
Matthaei, KI
McLennan, IS
机构
[1] Univ Otago, Sch Med Sci, Dept Anat & Struct Biol, Neuromuscular Res Grp, Dunedin, New Zealand
[2] John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 0200, Australia
关键词
mouse; transgenic; dominant negative receptor; transforming growth factor-beta; doxycycline; tetracycline-inducible expression; neuron;
D O I
10.1002/gene.20115
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The transforming growth factor-betas (TGF beta s) have multiple roles, making genetic analysis of their functions difficult. We therefore developed transgenic mouse lines to disrupt TGF beta signaling using a mechanism that is inducible, reversible, and cell-type specific. The transgenic mouse lines carry an EGFP-pBi-DeltaT-betaRII construct (PTR). The Delta T beta RII element codes for a dominant-negative receptor that is known to disrupt TGF beta signaling. The Delta T beta RII has a c-myc tag. The transgene was silent in the PTR mice, with expression of both EGFP and Delta T beta RII occurring when the PTR mice were crossed with mice that express the tetracycline transactivator (CMV-tTA). The expression of EGFP was repressed by the addition of doxycycline to the drinking water of the PTRxCMV-tTA mice. The PTR mice were then crossed with neuron-specific-tTA mice. Expression of the Delta T beta RII transgene in these mice led to an upregulation of native TGF beta receptor expression, suggesting that neurons can modulate their responsiveness to TGF beta s. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [41] CHARACTERIZATION OF DOUBLE TRANSGENIC MICE EXPRESSING HEPATOCYTE GROWTH-FACTOR AND TRANSFORMING GROWTH-FACTOR-ALPHA
    SHIOTA, G
    KAWASAKI, H
    NAKAMURA, T
    SCHMIDT, EV
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1995, 90 (01) : 17 - 24
  • [42] DISTRIBUTION AND MODULATION OF THE CELLULAR RECEPTOR FOR TRANSFORMING GROWTH-FACTOR-BETA
    WAKEFIELD, LM
    SMITH, DM
    MASUI, T
    HARRIS, CC
    SPORN, MB
    JOURNAL OF CELL BIOLOGY, 1987, 105 (02): : 965 - 975
  • [43] Transforming growth factor-beta receptor expression in human cornea
    Joyce, NC
    Zieske, JD
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (10) : 1922 - 1928
  • [44] AN ASSAY FOR TYPE-BETA TRANSFORMING GROWTH-FACTOR RECEPTOR
    WAKEFIELD, LM
    METHODS IN ENZYMOLOGY, 1987, 146 : 167 - 174
  • [45] Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair
    Gold, LI
    Sung, JJ
    Siebert, JW
    Longaker, MT
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 150 (01): : 209 - 222
  • [46] TARGETED EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA-1) TO THE EPIDERMIS LEADS TO LIVEBORN BUT NONVIABLE TRANSGENIC MICE
    SELLHEVER, K
    ROTHNAGEL, J
    BUNDMAN, D
    LONGLEY, M
    GEISER, A
    ROBERTS, A
    ROOP, D
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 510 - 510
  • [47] TARGETED EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA-1) TO THE EPIDERMIS LEADS TO LIVEBORN, BUT NONVIABLE TRANSGENIC MICE
    SELLHEYER, K
    ROTHNAGEL, J
    BUNDMAN, D
    LONGLEY, M
    GEISER, A
    ROBERTS, A
    ROOP, D
    CLINICAL RESEARCH, 1993, 41 (02): : A450 - A450
  • [48] Comparison of morphologic parameters of a series of gastric carcinomas with transforming growth factor beta RII mutation and microsatellite instability
    Dolinak, D
    Grady, W
    Rajput, A
    Willis, J
    Markowitz, S
    LABORATORY INVESTIGATION, 1997, 76 (01) : 302 - 302
  • [49] Mutation analysis of the transforming growth factor-beta type II receptor in human cell Lines resistant to growth inhibition by transforming growth factor-beta
    Vincent, F
    Nagashima, M
    Takenoshita, S
    Khan, MA
    Gemma, A
    Hagiwara, K
    Bennett, WP
    ONCOGENE, 1997, 15 (01) : 117 - 122
  • [50] Transforming growth factor-beta fails to inhibit allograft rejection or virus-induced autoimmune diabetes in transgenic mice
    Lee, MS
    Sawyer, S
    Arnush, M
    Krahl, T
    vonHerrath, M
    Oldstone, MBA
    Sarvetnick, N
    TRANSPLANTATION, 1996, 61 (07) : 1112 - 1113